Malignant Neoplasm of Stomach: Clinical Trials

6 trials for Malignant Neoplasm of Stomach, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Unknown 2

Follow Malignant Neoplasm of Stomach: new trials by email Literature Review of Malignant Neoplasm of Stomach trials Research Report on Malignant Neoplasm of Stomach

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
D2 radical gastrectomy, SOX neoadjuvant or postoperative chemotherapy, Hyperthermic intraperitoneal chemotherapy (HIPEC) - Malignant Neoplasm of Stomach
Phase 2UnknownWuhan University1002020-04-012020-04-14
Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
Hyperthermic intraperitoneal chemotherapy (HIPEC), D2 radical gastrectomy, SOX postoperative chemotherapy - Malignant Neoplasm of Stomach
Phase 2CompletedWuhan University1002015-08-012020-03-24
Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
Cisplatin, 5-fluorouracil or Capecitabine, Trastuzumab - Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC1722015-07-152025-07-31
Early Recovery After Gastric Cancer Surgery
Early recovery - Fasting, Malignant Neoplasm of Stomach
Phase 2UnknownAjou University School of Medicine1092012-07-012012-07-20
MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma
Oxaliplatin, Folinic Acid, 5-fluoro-uracil - Malignant Neoplasm of Esophagus, Malignant Neoplasm of Stomach
Phase 2CompletedUNICANCER1622011-01-012020-11-17
Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE
Capecitabine/Cisplatin + Sorafenib, Capecitabine/Cisplatin - Malignant Neoplasm of Stomach, Effects of Chemotherapy
Phase 2CompletedAsan Medical Center1952010-08-012020-01-07

Narrower conditions

Stomach Neoplasms (6)  ·  Adenocarcinoma (1)  ·  Esophageal Neoplasms (1)  ·  Fasting (1)

Broader conditions

Digestive System Diseases (6)  ·  Digestive System Neoplasms (6)  ·  Gastrointestinal Diseases (6)  ·  Gastrointestinal Neoplasms (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Stomach Diseases (6)  ·  Behavior (1)  ·  Carcinoma (1)  ·  Esophageal Diseases (1)  ·  Feeding Behavior (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Capecitabine (2)  ·  Cisplatin (2)  ·  Hyperthermic Intraperitoneal Chemotherapy (2)  ·  Drug Therapy (1)  ·  Fluorouracil (1)  ·  Gastrectomy (1)  ·  Leucovorin (1)  ·  Oxaliplatin (1)  ·  Panitumumab (1)  ·  Sorafenib (1)  ·  Surgical Procedures, Operative (1)  ·  Trastuzumab (1)  ·  pertuzumab (1)  ·  rilotumumab (1)

Sponsors

Wuhan University (2)  ·  Ajou University School of Medicine (1)  ·  Asan Medical Center (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  UNICANCER (1)

Countries

South Korea (3)  ·  China (2)  ·  France (2)  ·  Belgium (1)  ·  Estonia (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Portugal (1)  ·  Singapore (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Anna Dorothea Wagner, MD (1)

Results publications

PMID 27486629, PMID 31126258, PMID 31930513

NIH funding

2009 (1), 2014 (1)